Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardinal Eyeing Further Acquisitions In China

This article was originally published in PharmAsia News

Executive Summary

Cardinal Health's recent acquisition of Zuellig Pharma China (Yong Yu in Chinese) likely will not be the last China-based distributor the U.S. wholesaler will pick up, according to company CFO Jeff Henderson

You may also be interested in...

Alliance Boots Doubles Down In China With 12% Stake Of Nanjing Pharma

As MNCs increase stakes in China’s pharmaceutical distribution market, the highly segmented nature of the industry will remain a challenge for market penetration, analysts say.

Riding Consolidation Wave, Cardinal Health Looks To New Business Models In China

The second largest U.S. pharmaceutical distributor sees China as a growth engine and platform for innovation.

Cardinal's China Operations Running "Ahead Of Plan," More Expansion Ahead

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts